Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.

Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.

http://www.wikidata.org/entity/Q37109580

about

Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.Dysregulation of TTP and HuR plays an important role in cancers.Cell cycle RNA regulons coordinating early lymphocyte development.Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation.The role of RNA-binding protein tristetraprolin in cancer and immunity.Emerging role of HuR in inflammatory response in kidney diseases.Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1.

P2860

Q37686167-1038E4E2-7468-4373-A083-87877EBD192A Q38958552-5F7CB4DC-B656-41C9-B1C0-BA457666998B Q39148241-CEFC1732-010A-40B5-830C-C1196758771A Q45373509-8678E238-6F05-4905-BA92-0C6FDF6850D8 Q47417882-28906967-6208-4285-81F5-DAE52CCF0549 Q47801949-D1E65C56-E8D9-4A64-9EFC-CA987BC8E00F Q55408888-1D9596B6-E220-4E8B-AD72-40DAED82AF26

P2860

Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.

http://www.wikidata.org/entity/Q37109580

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@en

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@nl

type

label

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@en

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@nl

prefLabel

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@en

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@nl

P1433

Q37109580-4EDA599F-B882-43E8-9C84-9906851FEB18

P1476

Q37109580-0108BDCA-FB6C-43D2-BE1D-41C3BF2C1AFF

P2093

Q37109580-1DFC249A-EEBD-4167-828C-ED7D37BF156F

Q37109580-21BC9C0F-D0D4-4E88-A076-CE336D9326F7

Q37109580-288BCD5B-017A-4222-BD38-FF9B5CB08E74

Q37109580-4B8A9E5E-FA04-4A34-92BE-B4213AE67A19

Q37109580-75B205C5-51BF-42B6-96CD-9BFFC2045AFE

Q37109580-7FC5CD08-112C-452A-A40F-9C43B6001285

Q37109580-A08FFB6B-E0C8-46D1-B1AF-14CCC603B271

Q37109580-D14BEA09-9E9F-41E8-9173-698514D64367

P2860

Q37109580-02FBA1D8-11E7-4C99-9A11-3D56DEE13562

Q37109580-09FA1999-3D2F-479B-83E0-EEAF0D218A9F

Q37109580-0A0BE93F-0172-425A-B1E5-318F5FC74147

Q37109580-1323C5F2-5532-41D2-AA5C-F017D0CACB5D

Q37109580-16BA5B20-20FC-4E5C-BA67-AF9BAC17C62C

Q37109580-1B359355-0B52-4238-97F8-1F9972CF373B

Q37109580-515D7F35-763E-4E5A-957D-892D87E9EECB

Q37109580-53C54590-A87B-47B6-AF85-5A03CBC5CAD9

Q37109580-5F504904-961C-4E25-A94F-F87D6C24C18E

Q37109580-6C8EE0AE-F13F-4A76-A622-6D98AF780CDB

P304

Q37109580-B4DD3432-B79C-4D7F-A59C-993754EF8E21

P31

Q37109580-4B0B9802-643B-4A98-AF3B-403048768E81

P356

Q37109580-34FA8435-F6A1-4B32-987E-B359C1029893

P407

Q37109580-7A6EBFC4-E9BB-4F3C-91D1-A3070B8629F4

P433

Q37109580-DADEF900-0661-4807-8FA9-A4BCE6BB97D7

P478

Q37109580-B624F255-ECDE-4957-909C-897720B59B53

P577

Q37109580-42293C24-8CA1-4EDA-81D4-3FB2A2C64D72

P698

Q37109580-291C5609-D751-4C7F-8E63-3507E396EED8

P932

Q37109580-8BE8B1FD-66DB-4572-BBE2-F95607FCC02B

P356

ONCOTARGET.7397

P1433

P1476

Low tristetraprolin expression ...... outcome in pancreatic cancer.

@en

P2093

Chao Liang

http://www.w3.org/2001/XMLSchema#string

Dan Feng

http://www.w3.org/2001/XMLSchema#string

De-Jun Yang

http://www.w3.org/2001/XMLSchema#string

Qing-Ping Cai

http://www.w3.org/2001/XMLSchema#string

Wei-Min Wang

http://www.w3.org/2001/XMLSchema#string

Ya-Jun Cheng

http://www.w3.org/2001/XMLSchema#string

Yue-Xiang Wang

http://www.w3.org/2001/XMLSchema#string

Zi-Ran Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA.

The Hallmarks of Cancer

Hallmarks of Cancer: The Next Generation

Interactions of CCCH zinc finger proteins with mRNA: non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs

Inflammation and cancer

Cancer treatment and survivorship statistics, 2012

Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase

AU-rich elements: characterization and importance in mRNA degradation

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.

P304

17737-17750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.7397

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26894969

http://www.w3.org/2001/XMLSchema#string

P932

4951246

http://www.w3.org/2001/XMLSchema#string